Dual-Time-Point 18F-FDG PET/CT in Infective Endocarditis: Impact of Delayed Imaging in the Definitive Diagnosis of Endocarditis.
Amanda Padilla BermejoFrancisco José Pena PardoEdel Noriega-ÁlvarezMariano Amo-SalasMaría de Las Nieves Sicilia PozoAna María García VicenteVíctor Manuel Poblete-GarcíaPublished in: Biomedicines (2024)
Infective endocarditis (IE) is a major public health condition due to the associated high morbidity and mortality. Our objective was to evaluate the utility of dual-time 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) imaging in the diagnosis of active IE in patients with suspected native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE). For this purpose, a retrospective study was carried out, including patients suspicious of NVE or PVE who underwent a dual-time-point 18F-FDG PET/CT. A final diagnosis was established by the Endocarditis Team after patient follow-up using all the available findings. Sixty-nine patients were assessed. A final diagnosis of NVE was established in 3 patients of the 34 by 18F-FDG PET/CT and in the case of PVE was established in 20 patients of the 35. A statistically significant association was found when evaluating the association between PET diagnosis at early acquisition and final diagnosis of IE (χ 2 = 30.198, p < 0.001) and PET diagnosis at delayed acquisition for final diagnosis of IE (χ 2 = 9.412, p = 0.002). Delayed PET/CT imaging determined the IE diagnosis in 16/58 of the studies. In conclusion, delayed 18F-FDG PET/CT imaging seems to be useful in improving the definitive diagnosis of IE.
Keyphrases
- positron emission tomography
- pet ct
- computed tomography
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- magnetic resonance imaging
- heart failure
- pet imaging
- metabolic syndrome
- radiation therapy
- blood pressure
- type diabetes
- adipose tissue
- aortic stenosis
- photodynamic therapy